Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gambro Dialysatoren is a specialized medical technology company focused on the development and production of dialyzers and membranes for extracorporeal blood treatment. Headquartered in Hechingen, Germany, the company serves as a critical research, development, and manufacturing hub for its parent organization, Baxter. Its product portfolio includes advanced synthetic membranes used in hemodialysis, hemodiafiltration, and continuous renal replacement therapy. The company is recognized for its innovation in membrane science, particularly the development of high-flux dialyzers that improve toxin clearance while maintaining biocompatibility. As one of the world's largest production sites for dialyzers, it plays a vital role in the global supply chain for renal care products. The facility integrates sophisticated automated production lines with rigorous quality control to meet international medical device standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gambro Dialysatoren.